Why Teladoc Health Stock Dove 32% in November

Why Teladoc Health Stock Dove 32% in November

Teladoc Health (NYSE: TDOC) shareholders lost ground to the market last month as their stock dove 32% compared to a 0.8% decline in the S&P 500. According to data from S&P Global Market Intelligence, the slump helped push shares down over 50% so far in 2021 compared to an over 22% spike in the wider market. Investors sold shares off during last month's move against high-growth tech stocks, too.